Prescient Therapeutics LimitedASX: PTX

PTX-100 to Re-enter Trials in Hematology Niche

Oct 3, 2017 at 3:55 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment